Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study.

Identificadores
URI: https://hdl.handle.net/10481/100739
Exportar
RISMendeleyBibtex
Estadísticas
View Usage Statistics
Metadata
Show full item record
Author
Aomar Millán, I.; Salvatierra, Juan; Torres Parejo, Úrsula; Faro-Miguez, Naya; Callejas Rubio, José Luis; Ceballos Torres, Ángel; Cruces Moreno, María Teresa; Gómez Jiménez, Francisco Javier; Hernández Quero, José; Anguita-Santos, F.
Date
2021-06
Referencia bibliográfica
Aomar-Millán IF, Salvatierra J, Torres-Parejo Ú, Faro-Miguez N, Callejas-Rubio JL, Ceballos-Torres Á, Cruces-Moreno MT, Gómez-Jiménez FJ, Hernández-Quero J, Anguita-Santos F. Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study. Intern Emerg Med. 2021 Jun;16(4):843-852. doi: 10.1007/s11739-020-02600-z. (IF: 3.4; Q2)
Collections
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional